Pancreatic cancer is aggressive and deadly, and scientists have been searching for a cure. Now, a receptor known as ALK7 ...
Findings complement previously announced results in triple-negative breast cancer (TNBC) and prostate cancer models, highlighting Telomir-1’s consistent impact on cancer cell survival pathways. MIAMI, ...
Scientists have developed compounds that selectively block a crucial interaction between RAS and the enzyme PI3K, a driver of tumor growth. Scientists from the Francis Crick Institute and Vividion The ...
New findings show Telomir-1 shuts down cellular energy pathways and mitochondrial function in aggressive breast cancer cells, ...
In recognition of October as Breast Cancer Awareness Month, Sarah Premji, MD, assistant director of Breast Cancer Research at ...
Claudine Isaacs, MD: For this patient who's progressed after more than 12 months with an ESR1 mutation and HER2-low disease ...
Protocol-Stipulated Dose Modification to Manage Chemotherapy-Induced Peripheral Neuropathy in Children, Adolescents, and Young Adults With High-Risk Hodgkin Lymphoma We conducted a retrospective ...
(NASDAQ:MRNA) today announced that clinical, safety and translational data from its Phase 1/2 study evaluating mRNA-4359 in ...
Oncology rehabilitation and exercise (ORE) exist along a continuum of care, providing essential services for patients with cancer to improve health outcomes. Although oncology rehabilitation, ...
Race does not significantly impact tumor mutations of triple-negative breast cancer, suggesting genetics and environmental ...
Will giving oncologists financial incentives to "stay on track" help reign in cancer costs? At least one insurer, and maybe more in the future, are counting on it. WellPoint, one of the largest health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback